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Abstract
General synthetic routes to 4-methyl-5-arylpyrimidines and 5-arylpyrimidines are described. 4-Benzylpyrimidine, 4-
methyl-5-phenylpyrimidine, 4-(4-methoxybenzyl)pyrimidine, and 4-methyl-5-(4-methoxyphenyl)pyrimidine have been
positively identi®ed as route-speci®c by-products in the Leuckardt preparations of amphetamine and 4-methoxyamphetamine.
Using headspace solid phase microextraction (SPME) 4-(4-methoxybenzyl)pyrimidine and 4-methyl-5-(4-methoxyphe-
nyl)pyrimidine have been identi®ed in illicit tablets containing 4-methoxyamphetamine. This is an indication that illicit
laboratories use the Leuckardt method for the preparation of 4-methoxyamphetamine.
Flatliner tablets containing 4-methylthioamphetamine have been screened for the presence of 4-(4-methylthiobenzyl)pyr-
imidine and 4-methyl-5-(4-methylthiophenyl)pyrimidine using both headspace and aqueous phase SPME. As these
pyrimidines were not detected it would appear likely that illicit laboratories are not using the Leuckardt method for the
preparation of 4-methylthioamphetamine. # 2001 Elsevier Science Ireland Ltd. All rights reserved.
Keywords: Designer drugs; Leuckardt reaction; Solid phase microextraction; 4-Benzylpyrimidine; 4-Methyl-5-phenylpyrimidine; 4-(4-
Methoxybenzyl)pyrimidine; 4-Methyl-5-(4-methoxyphenyl)pyrimidine; 4-(4-Methylthiobenzyl)pyrimidine; 4-Methyl-5-(4-methylthiophe-
nyl)pyrimidine; Amphetamine; 4-Methoxyamphetamine; 4-Methylthioamphetamine
1. Introduction
In certain circumstances a forensic drug chemist
can be called upon to indicate the exact method by
which a synthetic illicit drug might have been man-
ufactured. For example, it can be of critical forensic
importance to indicate whether or not a chemical
collection in the possession of a suspect could have
been used to prepare a batch of drugs. Manufacturing
information also gives law enforcement agencies an
indication as to which chemicals should be subject to
sales control and monitoring, or even prohibited.
Two features of illicit drug synthesis make it pos-
sible to predict the route used. Firstly, as different
synthetic schemes utilise different raw materials, then
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different schemes can give rise to characteristic pro-
®les of chemical by-products. Secondly, for a given
synthetic scheme, minor variations in the parameters
associated with the reaction (e.g. temperature, molar
ratio of the reagents) might give rise to variations in
the yields of characteristic chemical by-products. Of
great interest to forensic drug chemists are the so-
called route-speci®c markers, these are by-products
that are unique to a speci®c synthetic method. If such
markers are detected in an illicit drug, then the for-
ensic drug chemist can con®dently predict the method
by which the material has been manufactured.
In the late 1970s two compounds that appeared to
be present only in amphetamine prepared from phe-
nyl-2-propanone via the Leuckardt synthesis were
detected by van der Ark et al. [1]. These two com-
pounds were identi®ed as 4-benzylpyrimidine (1) and
4-methyl-5-phenylpyrimidine (2). Unfortunately, it
would appear that the early work did not include
the unambiguous synthesis of these compounds fol-
lowed by the comparison of this authentic material
with the by-products from the Leuckardt reaction. As
a consequence, the assignment of identity must be
considered tentative. One of the goals of the work
described in this article was to synthesise authentic (1)
and (2) and thereby con®rm (or disprove) the identi-
®cations arrived at by van der Ark.
As described elsewhere [2±4], illicit 4-methoxyam-
phetamine (PMA) preparations have been the cause of
fatalities in Australia; in the past they have been the
cause of deaths in other countries [5,6]. Recent ana-
lysis of PMA tablets by us [4] led to the suggestion
that aryl pyrimidines were present. If this were true,
then by extension of the work of van der Ark it
indicates that the illicit material was prepared from
4-methoxyphenyl-2-propanone via the Leuckardt
reaction. Another goal of the work described herein
was to synthesise 4-(4-methoxybenzyl)pyrimidine (3)
and 4-methyl-5-(4-methoxyphenyl)pyrimidine (4) so
that intelligence relating to the illicit manufacture of
PMA might be gathered.
4-Methylthioamphetamine (MTA) is a relatively
new designer drug that emerged in Europe [7±10].
Similar to PMA, it appears to be a dangerous drug;
there have been fatal overdose outcomes in the Neth-
erlands and UK [11]. It has recently turned up in
seizures in Australia, but as yet there have been no
deaths attributed to its abuse. Currently the exact route
by which MTA is produced in illicit laboratories is not
known. Other goals of this work were to prepare the
Leuckardt-speci®c by-products 4-(4-methylthioben-
zyl)pyrimidine (5) and 4-methyl-5-(4-methylthiophe-
nyl)pyrimidine (6), and screen illicit preparations for
the presence of these compounds.
This paper describes synthetic routes to 4-arylpyri-
midines and 4-methyl-5-arylpyrimidines, and presents
characteristic analytical data for them. The synthetic
methodology presented is potentially applicable to the
synthesis of a wide variety of other pyrimidines
characteristic of the Leuckardt synthesis of many
designer amphetamine drugs.
2. Methods and techniques
2.1. Materials and instrumental methods
Two gas chromatograph±mass spectrometers were
used in this study, a Hewlett-Packard 5890 equipped
with a 5972 MSD and electronic pressure program-
ming, and a Hewlett-Packard 6890 equipped with a
5973 MSD and electronic pressure programming. For
SPME a glass liner of 0.75 mm i.d. was used in the
injector, while a standard split/splitless liner was used
for liquid injections.
Helium was used as carrier gas at a constant linear
¯ow rate of 62 cm/s for SPME and 55 cm/s for liquid
injection; the column was a 15 m0.257 mm
0.25 mm DB-1 fused silica capillary; for SPME the
oven program went from 508C (2 min delay) to 3008C
at a rate of 308C/min; for liquid injection the oven
program started at 908C (3 min delay) and went to
3008C at 458C/min, the injector was kept at 2908C (for
SPME) or 3008C for liquid injection; for SPME the
injector was run in the splitless mode for 30 s with a
pressure pulse of 20 psig for 30 s; for liquid injections
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the instrument was run in split mode using a 1 ml
injection and a split ¯ow of 50 ml/min; the mass
spectrometer operated from 40 to 400 Da in electron
impact mode, 70 eV, 3.6 scans per second.
The SPME `syringe' used was a Supelco manual
®bre holder equipped with a ®bre coated with an
85 mm thick polyacrylate solid phase.
1H and 13C NMR data were collected using a Varian
Gemini 200 spectrometer with deuterochloroform as
solvent. Resonances were measured in parts per mil-
lion relative to tetramethylsilane (d0.0) for hydro-
gen, and chloroform (d77.0) for carbon. Accurate
mass measurements were performed by the Organic
Mass Spectrometer Facility, Central Science Labora-
tory, University of Tasmania, while microanalyses
were performed by the Chemistry Department, Uni-
versity of Otago, New Zealand. Flash chromatography
was carried out using Merck silica gel 60 (230±
400 mesh) and redistilled solvents.
Melting points were recorded using a Reichert hot
stage melting point apparatus and are uncorrected.
2.2. Solid-phase microextraction of illicit
preparations
2.2.1. Headspace SPME
The illicit preparations (crushed if tablet form) were
placed into a 2 ml glass GC autosampler phial and
capped with a te¯on backed septum cap. After placing
the phial on its side, the septum was carefully pierced
with the SPME needle; it was allowed to protrude only
about 5 mm into the phial. The ®bre was then exposed
to the headspace at the appropriate temperature while
taking care not to allow the ®bre to touch powder.
Upon completion of headspace extraction the ®bre
was withdrawn into the needle, and then placed into
the injector of the gas chromatograph. The ®bre was
then exposed immediately to the hot interior of the
chromatographic injector and data acquisition com-
menced; the ®bre was left in place, exposed to the hot
environment, until required for the next extraction.
2.2.2. Aqueous SPME
A Flatliner (1/2 tablet) was dissolved in distilled
water (10 ml) and ®ltered through a 0.45 mm Nylon
®lter into a small beaker. The ®bre of an SPME device
was dipped into the liquid for 30 min while it was
stirred rapidly with the aid of a magnetic stirrer. After
this time the ®bre was rinsed with a few millilitre of
distilled water and exposed to the gas chromatograph
in the usual fashion.
2.2.3. Synthesis of trisformaminomethane
A mixture of diethyl sulphate (30.6 g) and forma-
mide (51 g) was heated with stirring at 70±808C for
2 h. The mixture was allowed to cool and the ethyl
formate that had formed was distilled off under
reduced pressure. The crystals that formed on cooling
were collected, washed with cold absolute methanol
(5 ml) and dried under vacuum to yield trisformami-
nomethane (7.8 g) as white crystals (Lit. mp 164±
1658C [12], 163±1648C).
2.2.4. Synthesis of 4-methyl-5-phenylpyrimidine (2)
4-Methyl-5-phenylpyrimidine was prepared using
the method of Koyama et al. [13]. A mixture of
phenyl-2-propanone (2.21 g), trisformaminomethane
(5 g), p-toluenesulphonic acid (0.2 g), and formamide
(3.5 ml) was heated at 150±1608C with stirring for 8 h.
The mixture was allowed to stand at room temperature
overnight whereupon it was made alkaline with
sodium hydroxide (2 M, 4 ml) and extracted with
dichloromethane (420 ml). The combined organic
extracts were dried over anhydrous sodium sulphate
and then concentrated in vacuo to yield an oil. The oil
was dissolved in a minimum quantity of hot hexane
that, on cooling, yielded the pyrimidine as yellow
crystals (0.91 g, 32%, Lit. mp 75±75.58C [13], 76±
76.58C).
1H NMR d: 2.52 singlet (3H), 7.4 multiplet (5H),
8.54 singlet (1H), 9.08 singlet (1H). 13C NMR: d:
22.83, 128.33, 128.77, 128.98, 134.85, 135.83,
156.32, 157.17, 164.42. Mass spectrum 170 Da
(M, 80%), 169 (64%), 115 (50%), 102 (100%)
(Fig. 1).
2.3. Synthesis of 4-methylthiophenyl-2-propanone
(8) via 1-(4-methylthiophenyl)-2-nitropropene (11)
A mixture of 4-methylthiobenzaldehyde (30.5 g),
nitroethane (15 g), ethanol (35 ml) and butylamine
(4 ml) was heated under re¯ux for 8 h. The mixture
was then cooled to 08C and the crystals that formed
were collected and washed with cold ethanol. Con-
centration of the mother liquor afforded another crop
of crystals. Recrystallisation from ethanol yielded
K.P. Kirkbride et al. / Forensic Science International 115 (2001) 53±67 55
1-(4-methylthiophenyl)-2-nitropropene (32.75 g, 78%)
as bright yellow crystals, melting point 71±738C.
Microanalysis: found: C, 57.52%; H, 5.32%; N,
6.69%. C10H10NO2S requires C, 57.40%; H, 5.30%;
N, 6.69%. 1H NMR d: 2.51 singlet (3H), 2.56 singlet
(3H), 7.40 multiplet (4H), 8.13 singlet (1H). 13C NMR
d: 14.15, 15.05, 125.94, 128.63, 130.48, 133.17,
142.16, 146.92. Mass spectral data agreed well with
those published by Poortman-van der Meer [8], 209 Da
(M, 26%), 162 (46%), 115 (100%); see Fig. 2. Con-
centratedhydrochloricacid (10 ml)wasaddeddropwise
over 1 h to a re¯uxing mixture of iron ®lings (20.75 g),
ferric chloride (5 g), and 1-(4-methylthiophenyl)-2-
nitropropene (10.8 g) in water (75 ml). After addition
of the acid was complete the mixture was heated under
re¯ux for an additional 7 h whereupon it was cooled and
subjected to steam distillation (500 ml distillate col-
lected). The distillate was extracted with diethyl ether
(480 ml), the combined organic extracts were dried
over anhydrous sodium sulphate, then concentrated in
vacuo to yield 4-methylthiophenyl-2-propanone as a
yellow oil (2 g, 22%).
1H NMR d: 2.15 singlet (3H), 2.47 singlet (3H),
3.65 singlet (2H), 7.17 multiplet (4H). 13C NMR d:
Fig. 1. Mass spectrum for 4-methyl-5-phenylpyrimidine (2).
Fig. 2. Mass spectrum for 1-(4-methylthiophenyl)-2-nitropropene (11).
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15.88, 29.17, 50.31, 127.04, 129.80, 131.02, 137.19,
205.99. Mass spectrum 180 Da (M, 18%), 137
(100%), 122 (25%); see Fig. 3. Accurate mass, found
180.0609 Da, C10H12OS requires 180.0609.
2.4. Synthesis of 4-methyl-5-(4-
methoxyphenyl)pyrimidine (4)
A mixture of 4-methoxyphenyl-2-propanone (2 g),
trisformaminomethane (3.7 g), p-toluenesulphonic
acid (0.15 g), and formamide (2.5 ml) was heated
under re¯ux at 150±1608C for 8 h then allowed to
cool to room temperature overnight. The resulting
mixture was made alkaline with sodium hydroxide
(2 M, 2 ml) then extracted with dichloromethane
(325 ml). The combined organic extracts were
washed with water (320 ml), dried over anhydrous
magnesium sulphate, and concentrated in vacuo to
yield an oil. The oil was taken up in a minimum
quantity of hot hexane which, when cooled, afforded
4-methyl-5-(4-methoxyphenyl)pyrimidine (0.6 g,
25%) as yellow crystals, melting point 56±588C.
Microanalysis: found: C 71.76%, H 6.08%, N
13.72%, C12H12N2O requires C 71.97%, H 6.04%,
N 13.99%. 1H NMR d: 2.53 singlet (3H), 3.88 singlet
(3H), 7.02 multiplet (2H), 7.23 multiplet (2H), 8.52
singlet (1H), 9.05 singlet (1H). 13C NMR d: 22.83,
55.31, 114.22, 127.94, 130.14, 150.67, 156.29,
156.77, 159.67, 164.43. Mass spectrum 200 Da
(M, 100%), 185 (17%), 132 (19%), 117 (25%), 89
(14%); see Fig. 4.
2.5. Synthesis of 4-methyl-5-(4-
methylthiophenyl)pyrimidine (6)
A mixture of 4-methythiophenyl-2-propanone
(2.4 g), trisformaminomethane (3.98 g), p-toluenesul-
phonic acid (0.2 g), and formamide (4.8 ml) was heated
underre¯uxat1308Cfor6 hthenallowedtocool toroom
temperature overnight. The resulting mixture was made
alkaline with sodium hydroxide (1.25 M, 2 ml) then
extracted with dichloromethane (250 ml). The com-
bined organic extracts were washed with water
(220 ml), dried over anhydrous sodium sulphate,
and concentrated in vacuo to yield an oil. Flash chro-
matography of the oil on silica gel using ethyl acetate/
dichloromethane (1:1) afforded 4-methyl-5-(4-methy-
thiophenyl)pyrimidine (0.66 g, 23%) as yellow oil.
1H NMR d: 2.53 singlet (3H), 2.55 singlet (3H),
7.31 multiplet (4H), 8.52 singlet (1H), 9.07 singlet
(1H). 13C NMR d: 22.86, 55.64, 126.51, 129.36,
129.71, 134.35, 156.29, 157.11, 158.77, 164.44. Mass
spectrum 216 Da (M, 100%), 201 (14%), 168 (20%),
133 (43%); see Fig. 5. Accurate mass, found
216.0717 Da, C12H12N2S requires 216.0721.
2.6. Synthesis of 4-benzylpyrimidine (1)
This method, and those described below for other 4-
arylpyrimidines, is based on that reported by Brederek
et al. [12]. Benzyl chloride (1.95 g) in anhydrous
diethyl ether (8 ml) was added dropwise over a period
of 10 min to a stirred mixture of magnesium turnings
Fig. 3. Mass spectrum for 4-methylthiophenyl-2-propanone (8).
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(0.31 g), diethyl ether (20 ml), and a small crystal of
iodine under a nitrogen atmosphere. The mixture was
heated under re¯ux until all of the magnesium had
been consumed, cooled to 108C, then treated dropwise
with a solution of pyrimidine (1.0 g) in diethyl ether
(8 ml) at such a rate that the mixture did not boil. After
addition of pyrimidine the mixture was stirred at room
temperature overnight then treated with a solution of
aqueous ammonium chloride (saturated, 2 ml). The
two phases were separated, the organic phase washed
with water (20 ml), and the aqueous phase extracted
with chloroform (220 ml). The combined organic
phases were dried over anhydrous sodium sulphate
and concentrated in vacuo to yield an oil. The oil was
taken up in a few ml of acetone then treated with a
saturated solution of potassium permanganate in ace-
tone until no more manganese dioxide formed. The
resulting solution was ®ltered, concentrated in vacuo,
and puri®ed by ¯ash chromatography on silica gel
(elution with ethyl acetate/hexane, 1:3) to yield 4-
benzylpyrimidine as a pale brown oil (0.6 g, 25%).
1H NMR d: 4.12 singlet (2H), 7.10 doublet (1H,
5.2 Hz), 7.3 multiplet (5H), 8.59 doublet (1H, 5.2 Hz),
9.15 singlet (1H). 13C NMR d: 44.15, 120.50, 126.94,
128.79, 129.19, 137.29, 156.94, 158.71, 169.33. Mass
spectrum 170 Da (M, 32%), 169 (100%), 115 (25%),
91 (30%); see Fig. 6. Accurate mass, found
170.0839 Da, C11H10N2 requires 170.0844.
Fig. 4. Mass spectrum for 4-methyl-5-(4-methoxyphenyl)pyrimidine (3).
Fig. 5. Mass spectrum for 4-methyl-5-(4-methylthiophenyl)pyrimidine (5).
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2.7. Synthesis of 4-(4-methoxybenzyl)pyrimidine (3)
4-Methoxylbenzyl chloride was prepared from 4-
methoxybenzyl alcohol using the method of Koyama
et al. [13]. 4-Methoxylbenzyl chloride (1.96 g) in
anhydrous tetrahydrofuran (8 ml) was added dropwise
under nitrogen to a stirred mixture of magnesium
turnings (0.31 g), tetrahydrofuran (8 ml) and a crystal
of iodine at such a rate that gentle re¯ux was main-
tained. The mixture was heated under re¯ux until all of
the magnesium had been consumed, cooled to 108C,
then treated dropwise with pyrimidine (1.0 g) at such a
rate that the mixture did not exceed 308C. After
addition of pyrimidine the mixture was stirred at room
temperature overnight then treated with a solution of
aqueous ammonium chloride (saturated, 2 ml). The
two phases were separated, the organic phase washed
with water (450 ml), and the aqueous phase
extracted with diethyl ether (250 ml). The combined
organic phases were dried over anhydrous sodium
sulphate and concentrated in vacuo to yield an oil.
The oil was taken up in a few ml of acetone then
treated with a saturated solution of potassium per-
manganate in acetone until no more manganese diox-
ide formed. The resulting solution was ®ltered,
concentrated in vacuo, and puri®ed by ¯ash chroma-
tography on silica gel (elution with ethyl acetate/
hexane, 1:4) to yield 4-(4-methoxybenzyl)pyrimidine
as a pale yellow oil (0.4 g, 16%).
1H NMR d: 3.80 singlet (3H), 4.06 singlet (2H),
6.87 AA0 of AA0XX0 (2H), 7.10 doublet (1H, 5 Hz),
7.18 XX0 of AA0XX0 (2H), 8.58 doublet (1H, 5 Hz),
9.14 singlet (1H). 13C NMR d: 43.31, 55.25, 114.28,
120.42, 129.35, 130.23, 156.93, 158.68, 169.81 (sig-
nal due to quarternary carbon not detected). Mass
spectrum 200 Da (M, 100%), 199 (65%), 185
(55%), 157 (18%), 121 (62%), 77 (14%); see Fig. 7.
Accurate mass, found 200.0949 Da, C12H12N2O
requires 200.0950.
2.8. Synthesis of 4-(4-methylthiobenzyl)pyrimidine
(5)
4-Methylthiobenzyl chloride was prepared from
thioanisole using the method of Pines et al. [15]. 4-
Methylthiobenzyl chloride (3.0 g) in anhydrous
diethyl ether (10 ml) was added dropwise under a
nitrogen atmosphere to a stirred mixture of magne-
sium turnings (0.41 g), diethyl ether (20 ml), and a
small crystal of iodine at such a rate that gentle re¯ux
was maintained. The mixture was heated under re¯ux
until all of the magnesium had been consumed, cooled
to 108C, then treated dropwise with a solution of
pyrimidine (0.6 g) at such a rate that the mixture
did not boil. After addition of pyrimidine the mixture
was stirred at room temperature overnight then treated
with water (30 ml). The organic phase was removed,
the aqueous phase extracted with diethyl ether
(220 ml), then the combined organic phases were
washed with water (350 ml) and dried over anhy-
drous sodium sulphate. Concentration of the organic
phase in vacuo yielded an oil. The oil was taken up in
Fig. 6. Mass spectrum for 4-benzylpyrimidine (1).
K.P. Kirkbride et al. / Forensic Science International 115 (2001) 53±67 59
chloroform and oxygen was bubbled through for 3
days. Concentration of the mixture in vacuo followed
by puri®cation of the resulting oil by ¯ash chromato-
graphy on silica gel (elution with ethyl acetate/hexane,
1:3) yielded 4-(4-methylthiobenzyl)pyrimidine as a
pale yellow oil (0.3 g, 20%).
1H NMR d: 2.47 singlet (3H), 4.10 singlet (2H),
7.11 doublet (1H, 4.6 Hz), 7.17 multiplet (4H), 8.59
doublet (1H, 4.6 Hz), 9.13 singlet (1H). 13C NMR d:
15.97, 43.63, 120.49, 127.21, 129.01, 129.71, 134.18,
157.03, 158.77 (signal due to quarternary carbon not
detected). Mass spectrum 216 Da (M, 100%), 201
(32%), 168 (58%), 137 (60%), 122 (33%); see Fig. 8.
Accurate mass, found 216.0717 Da, C12H12N2S
requires 216.0721.
3. Results and discussion
3.1. Synthesis of pyrimidines
A search of the chemical literature indicated that of
the six pyrimidines listed above, only 4-methyl-5-
phenylpyrimidine (2) has been synthesised. Koyama
et al. [13] treated phenyl-2-propanone with trisforma-
minomethane (CH(NHCHO)3, TFM) in formamide
Fig. 7. Mass spectrum for 4-(4-methoxybenzyl)pyrimidine (3).
Fig. 8. Mass spectrum for 4-(4-methylthiobenzyl)pyrimidine (5).
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with an acid catalyst to form (2). In our hands, the
method of Koyama et al. readily yielded (2) and, by
extension, was directly applicable to the synthesis of
(4) and (6) from 4-methoxyphenyl-2-propanone (7)
and 4-methylthiophenyl-2-propanone (8), respectively.
As there was no literature precedent for the synth-
eses of 4-arylpyrimidines such as (1), (3), and (5), a
synthetic route had to be devised. There were indica-
tions, however, that other 4-substituted pyrimidines
had been prepared by nucleophilic displacement reac-
tions upon 4-chloropyrimidine [16], or by addition of
Grignard reagents to pyrimidine followed by oxida-
tion [12]. The action of benzylmagnesium chloride
upon 4-chloropyrimidine failed to yield any 4-ben-
zylpyrimidine; a complex mixture of compounds was
produced. However, benzylmagnesium chloride did
add readily to pyrimidine to yield 4-benzyl-3,4-dihy-
dropyrimidine (9), which was readily oxidised to (1)
using potassium permanganate (Scheme 1). Similarly,
(3) and (5) were prepared by treating pyrimidine with
4-methoxybenzylmagnesium chloride and 4-thio-
methylbenzylmagnesium chloride, respectively, fol-
lowed by oxidation. As it was felt that the use of
potassium permanganate in the preparation of (5)
might lead to concomitant oxidation of the methylthio
moeity, oxygen gas was used instead. The position of
attack by the Grignard reagent upon pyrimidine was
readily determined from 1H NMR data, in particular
all products clearly showed a singlet resonance at
approximately d9.15 and doublets near 7.1 and 8.6.
3.2. Pyrimidines as markers for the Leuckardt
reaction
A trial preparation of amphetamine using the
Leuckardt reaction was performed. The crude reaction
mixture (after acid hydrolysis) was examined by GC±
MS (see Fig. 9). Using retention time and mass
spectral data obtained from the synthesised authentic
(1) and (2) as a guide, both of these compounds were
con®rmed as by-products in the Leuckardt reaction
product. The suggestions put forward by van der Ark
[1] that (1) and (2) are markers for the Leuckardt
reaction have therefore been con®rmed.
A trial preparation of PMA via the Leuckardt
reaction was also conducted. GC±MS (see Fig. 10)
indicated that both (3) and (4) were present as by-
products in this reaction.
In both Leuckardt reaction trials it was found that
the 4-methyl-5-arylpyrimidines were produced in
much greater abundance (about 5:1 ratio) than the
4-arylpyrimidines.
It should also be pointed out that using the gas
chromatographic conditions as described in Section 2,
we found that the pyrimidines virtually co-elute with
their related formylamphetamine, forming a convo-
luted envelope. Therefore, in Leuckardt reaction
Scheme 1.
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product that has not been completely hydrolysed, the
formyl amphetamine might mask the presence of
pyrimidines. This ®nding indicates that careful control
of the chromatographic conditions is required for drug
pro®ling, or careful inspection of chromatographic
data should be performed.
3.3. Pyrimidines in illicit preparations
Earlier work by us [4] and others [17] has indicated
that solid-phase micro-extraction (SPME) is a valu-
able technique that is complimentary to liquid±liquid
extraction for the generation of manufacturing by-
Fig. 9. GC±MS data for trial Leuckardt preparation of amphetamine (after hydrolysis). Crude reaction extract in dichloromethane was
injected as a liquid sample into the chromatograph. The compounds eluting at 5.01 and 4.96 min, respectively, were identi®ed as 4-
benzylpyrimidine (1) and 4-methyl-5-phenylpyrimidine (2) on the basis of their retention time and mass spectral data (see Figs. 6 and 1,
respectively). The over-range peak at 2.5 min is due to amphetamine, while the peak eluting between (1) and (2) was residual N-
formylamphetamine.
Fig. 10. GC±MS data for trial Leuckardt preparation of 4-methoxyamphetamine (after hydrolysis). Crude reaction extract in dichloromethane
was injected as a liquid sample in the instrument. The compounds eluting at 7.90 and 8.00 min were identi®ed as 4-methoxybenzylpyrimidine
(3) and 4-methyl-5-(4-methoxyphenyl)pyrimidine (4), respectively, on the basis of their retention time and mass spectral data (see Figs. 4 and
7). The distorted peak at 4.22 min is due to 4-methoxyamphetamine, while the peak eluting very close to (3) and (4) was residual N-formyl-4-
methoxyamphetamine.
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product pro®les of illicit tablets and powders. In
particular the method is rapid, simple, and offers
repeatability comparable to liquid±liquid extraction.
Under the SPME conditions described [4,17], extrac-
tion of tablet excipients and the active drug was
minimal. As a consequence extracts were relatively
rich in manufacturing by-products, but de®cient with
respect to the active drug and excipients, even though
these compounds are usually present in relatively high
abundance in illicit tablets and powders. Compared to
analysis of liquid extracts derived from illicit prepara-
tions, gas chromatography of `clean' SPME extracts
did not suffer from problems arising from injection of
high concentrations of drug and excipients.
In the current study headspace SPME in conjunc-
tion with GC±MS was used to screen several illicit
PMA preparations. A typical chromatogram is pre-
sented in Fig. 11. As demonstrated in our previous
work, the impurity pro®le is free from contributions
arising from PMA as the drug is present in the illicit
preparations as its involatile salt. In all the pills
examined both (3) and (4) were detected, an indication
Fig. 11. GC±MS data for headspace SPME performed at 658C for 30 min over one-half of an illicit tablet containing 4-methoxyamphetamine;
bottom trace is an expansion of the data between 6 and 8 min. The identity of the compound eluting at 7.10 min was con®rmed using retention
time and mass spectral data as 4-(4-methoxybenzyl)pyrimidine (3), while the compound eluting at 7.13 min was con®rmed as 4-methyl-5-(4-
methoxyphenyl)pyrimidine (4). The compound eluting at 5.54 min was identi®ed as 4-methoxyphenyl-2-propanone (7), that at 4.79 min was
identi®ed as 4-methoxybenzaldehyde, and that at 4.67 min was identi®ed as 4-methoxyphenol.
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that local PMA is manufactured using the Leuckardt
reaction. As reported previously [4] it would appear
that the 4-methoxyphenyl-2-propanone used in the
illicit manufacture of the drug was itself of illicit
manufacture, presumably originating from 4-methox-
ybenzaldehyde. However, it is still unclear as to
the exact conditions under which the ketone was
produced.
Several illicit tablets containing 4-methylthioam-
phetamine were screened for the presence of pyrimi-
dines using headspace SPME-GC±MS. The tablets
used weighed about 0.3 g, and were white, half-
scored; the only active compound present appeared
to be methylthioamphetamine. Such preparations are
the only type to be encountered so far in Australia, and
they appear to be identical to some preparations
encountered in UK [9,11]. Other tablets reported in
Europe have been heavier and larger than local speci-
mens, and caffeine has been present as well as the
active drug [7,8,10,11]. Except for seizures in Ger-
many and Switzerland, where the tablets featured a
®ve pointed star design, all other tablets encountered
in Europe and Australia have been ¯at, half-scored
and white, characteristics that have led to the nick-
name `Flatliners' being adopted [11].
A seizure of 1-(4-methylthiophenyl)-2-nitropro-
pene (11) in Europe [10] suggests that illicit 4-
methylthioamphetamine might be derived from this
compound. However, there is no evidence to indicate
exactly how this transformation was brought about;
(11) might have been reduced directly to 4-
methylthioamphetamine, or it might have been con-
verted into 4-methylthiophenyl-2-propanone which in
turn was elaborated into 4-methylthioamphetamine
using, for example, the Leuckardt reaction. In order
to investigate the question of the intermediacy of the
Leuckardt reaction, it was decided to screen `Flatli-
ners' for the presence of pyrimidines (5) and (6).
Headspace SPME experiments on `Flatliners' were
carried out both at room temperature for short periods
(about 5 min) and elevated temperatures (60 and
808C) for 30 min. Using these extraction conditions,
and with the mass spectrometer operating under full
scan acquisition, neither (5) nor (6) was detected (see
Fig. 12). In case the concentration of (5) or (6) was too
low in the headspace for reliable detection, SPME was
also carried out on an aqueous solution of a Flatliner
tablet. As can be seen in Fig. 13, SPME from the
aqueous phase did result in an increase in abundance
of high molecular weight compounds extracted, but
Fig. 12. GC±MS data for headspace SPME performed at 808C for 30 min over one-half of an illicit tablet containing 4-
methylthioamphetamine. Under the chromatographic conditions used, 4-(4-methylthiobenzyl)pyrimidine (5) and 4-methyl-5-(4-methylthio-
phenyl)pyrimidine (6) elute at close to 8 min. Compounds with mass spectral data corresponding to those for (5) and (6) were not detected. 1-
(4-Methythiophenyl)-2-nitropropene (11) was not detected. The compound eluting at 5.53 min was identi®ed as 4-methylthiobenzaldehyde
(10), at 5.75 min 4-methythiobenzyl alcohol (13) was tentatively identi®ed, at 6.13 min 4-methylthiophenyl-2-propanone (8) was identi®ed,
and at 6.17 min 4-methylthiophenyl-2-propanol (12) was tentatively identi®ed. The mass spectral data for these compounds are given in Figs. 3
and 14±16. The large peaks at 6.96, 7.64, and 8.26 min were tentatively identi®ed as fatty acids, while the peak at 9.27 min was tentatively
identi®ed as a phthalate ester.
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again neither (5) nor (6) was detected. It would there-
fore appear likely that 4-methylthioamphetamine, or
at least that available locally, is not produced via the
Leuckardt method.
As a result of the synthetic work towards 4-methyl-
5-(4-methylthiophenyl)pyrimidine (6), authentic spe-
cimens of 4-methylthiophenyl-2-propanone (8), 4-
methylthiobenzaldehyde (10), and 1-(4-methylthio-
phenyl)-2-nitropropene (11) were at hand. It was
possible to con®rm the presence of both (8) and
(10) in the headspace SPME extract of the Flatliner
tablets; nitropropene (11) was not detected however.
Fig. 13. GC±MS data for SPME performed on an aqueous solution of one half of an illicit tablet containing 4-methylthioamphetamine. Under
the conditions used neither (5) nor (6) nor (11) were detected. 4-Methylthiobenzaldehyde (10) was identi®ed at 5.53 min, 4-methylthiobenzyl
alcohol (13) was tentatively identi®ed at 5.74 min, and 4-methylthiophenyl-2-propanone (8) was identi®ed at 6.11 min. Compared to
headspace extraction for the same illicit preparation (see Fig. 12), three differences were noted using extraction from aqueous solution. Firstly,
the abundance of the substance eluting at 5.77 min is greatly enhanced; this compound is as yet unidenti®ed, but it appears to be either 1-(4-
methylthiophenyl)propene or 1-(4-methylthiophenyl)-2-propene on the basis of its mass spectral data (see Fig. 17). Secondly, a trace of 4-
methylthioamphetamine was detected at 6.16 min. Finally, compounds at higher molecular weight were recovered, but the level of fatty acid
extraction is relatively low.
Fig. 14. Mass spectrum for compound eluting at 5.53 min in Fig. 12, identi®ed as 4-methylthiobenzaldehyde (10).
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Fig. 15. Mass spectrum for compound eluting at 5.77 min in Fig. 12, tentatively identi®ed as 4-methylthiobenzyl alcohol (13).
Fig. 16. Mass spectrum for compound eluting at 6.17 min in Fig. 12, tentatively identi®ed as 4-methylthiophenyl-2-propanol (12).
Fig. 17. Mass spectrum for unknown compound (possibly 1-(4-methylthiophenyl)propene or 1-(4-methylthiophenyl)-2-propene) eluting at
5.77 min as extracted from an aqueous solution of a `Flatliner' tablet (see Fig. 13).
In addition, a tentative identi®cation of 4-methylthio-
phenyl-2-propanol (12) and 4-methylthiobenzyl alco-
hol (13) in the extract was made. Mass spectral data
for these compounds are presented (Figs. 14±17). The
presence of (8) and (13) in other Flatliners has been
reported elsewhere [9,14].
Although it would appear that the illicit route to
MTA involves a reductive step, the exact pathway is
still unclear.
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